Europeiska unionen -
svenska -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetylfumarat - multipel skleros, skovvis förlöpande - immunsuppressiva - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Europeiska unionen -
svenska -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimetylfumarat - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunsuppressiva - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
methylphenidate 2care4 54 mg depottablett
2care4 aps - metylfenidathydroklorid - depottablett - 54 mg - butylhydroxitoluen hjälpämne; laktosmonohydrat hjälpämne; metylfenidathydroklorid 42 mg aktiv substans; metylfenidathydroklorid 12 mg aktiv substans - metylfenidat
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
methylphenidate 2care4 18 mg depottablett
2care4 aps - metylfenidathydroklorid - depottablett - 18 mg - butylhydroxitoluen hjälpämne; laktosmonohydrat hjälpämne; metylfenidathydroklorid 4 mg aktiv substans; metylfenidathydroklorid 14 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
methylphenidate 2care4 18 mg depottablett
2care4 aps - metylfenidathydroklorid - depottablett - 18 mg - butylhydroxitoluen hjälpämne; laktosmonohydrat hjälpämne; metylfenidathydroklorid 4 mg aktiv substans; metylfenidathydroklorid 14 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
methylphenidate 2care4 54 mg depottablett
2care4 aps - metylfenidathydroklorid - depottablett - 54 mg - butylhydroxitoluen hjälpämne; laktosmonohydrat hjälpämne; metylfenidathydroklorid 12 mg aktiv substans; metylfenidathydroklorid 42 mg aktiv substans
Sverige -
svenska -
Läkemedelsverket (Medical Products Agency)
methylphenidate orifarm 54 mg depottablett
orifarm ab - metylfenidathydroklorid - depottablett - 54 mg - butylhydroxitoluen hjälpämne; laktosmonohydrat hjälpämne; metylfenidathydroklorid 42 mg aktiv substans; metylfenidathydroklorid 12 mg aktiv substans